Health Care Regulation

Health Care Regulation

{016D8801-6F40-42D6-A17E-767D2CEAEBDD}

With aging populations and budget constraints, national health care laws and programs will evolve rapidly over the next decade. The development and implementation of new health care approaches is complex, requiring that governments consider the views, experience and concerns of the entire health care community. We want to ensure you are heard.

Whether you are a health plan, health service provider, health care product manufacturer, or clinician, you will need to comply with current and evolving health policy and legislation simultaneously. By working together, we can develop and execute flexible business plans that respond to new opportunities and challenges as they arise. Dentons offers a global perspective to meet your unique needs.

Our health care regulation team members include former high-ranking government officials, health care regulatory compliance veterans, and health policy professionals. When you are seeking counsel on corporate or regulatory compliance, fraud/abuse, or government and private health care programs and plans, partnering with us will bring you successful outcomes.

Experience

Global insurance company: Providing on an ongoing basis advice to the entire company market, as well as individual managing agents, underwriters, and companies, regarding the development and implementation of US federal healthcare legislation. The focus is on identifying which coverages are or may be subject to the provisions for the federal law, insofar as even inadvertently writing subject healthcare coverage can expose an insurer to guaranteed renewability, minimum loss ratios, and other long-term and potentially substantial financial impacts. By helping the market understand the federal laws and applicable exemptions, we are able to help the market provide the coverage their clients need without incurring obligations that were not contemplated or compensated.

Insights

Post-Chevron and Beyond – Administrative Law Resource Center

July 10, 2024

At the end of the Supreme Court’s 2023-24 term, the Court’s conservative majority effected a sea-change in federal administrative law, asserting a stronger role for the courts in the regulatory state and bringing into question the legality and viability of many regulatory programs.

Exporting pharmaceutical products to Uzbekistan: 10 key factors to consider

March 18, 2024

Uzbekistan: The pharmaceutical market in Uzbekistan was estimated in 2022 to be worth UZS 19.9 trillion (approximately US$1.8 billion), with prescription drugs accounting for 78 percent and over-the-counter medicines making up the remaining 22 percent. Every aspect of a medicine’s lifecycle—from development and manufacturing to distribution, advertising and sales—is subject to Uzbekistan regulations.

CMS Continues Efforts to Reform Medicare Advantage and Part D Programs with New Proposed Rule

November 16, 2023

United States: The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule on November 15, 2023 containing potential revisions to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit (Part D) programs.

View all insights for Health Care Regulation